Loading patent…
AssigneeUcb Biopharma Sprl
InventorsRalph Adams, Pallavi Bhatta, Sam Philip Heywood, David Paul Humphreys
Estimating the term…
A serum albumin binding antibody or fragment thereof comprising a heavy chain variable domain having the sequence given in SEQ ID NO: 1 or SEQ ID NO:2 and/or comprising a light chain variable domain having the sequence given in SEQ ID NO:3 or SEQ ID NO:4, in particular comprising a heavy chain variable domain and a light chain variable domain having the sequence given in SEQ ID NO: 1 and SEQ ID NO:3 or a heavy chain variable domain and a light chain variable domain having the sequence given in SEQ ID NO: 2 and SEQ ID NO:4. The disclosure also extends to polynucleotides encoding the antibodies or fragments, vectors comprising same and host cells capable of expressing the polynucleotides. The disclosure further includes pharmaceutical compositions comprising the antibodies or fragments and therapeutic used of any one of the same.
A serum albumin binding antibody or fragment thereof comprising a heavy chain variable domain having the sequence given in SEQ ID NO:
A serum albumin binding antibody or fragment thereof comprising a light chain variable domain having the sequence given in SEQ ID NO:3 or SEQ ID NO:4.
A serum albumin binding antibody or fragment thereof comprising a heavy chain variable domain having the sequence given in SEQ ID NO:
A serum albumin binding antibody or fragment thereof comprising a heavy chain variable domain having the sequence given in SEQ ID NO:2 and a light chain variable domain having the sequence given SEQ ID NO:4.
A bispecific antibody fusion protein comprising:
Dependencies are inferred from the claim text.